Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Walker, Ruth H ^a,b   Moore, Cindy ^c   Davies, Georgia ^a   Dirling, Lisa B ^c   Koch, Rick J ^a   Meshul, Charles K ^c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; OXIDOPAMINE; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; BRAIN NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DENDRITIC CELL; DENDRITIC SPINE; DENSITY; DISEASE ACTIVITY; GLUTAMATERGIC TRANSMISSION; IMMUNOGOLD LABELING; MALE; NERVE ENDING; NEUROSECRETION; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PROTEIN LOCALIZATION; RAT; SENSORY NERVE CELL; STRIATE CORTEX; SUBTHALAMIC NUCLEUS; SYNAPSE VESICLE; SYNAPTOSOME; THALAMUS; ANALYSIS OF VARIANCE; ANIMAL; BASAL GANGLION; ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SENSORY NERVE; SYNAPTIC TRANSMISSION;

RATTUS;

AFFERENT PATHWAYS; ANALYSIS OF VARIANCE; ANIMALS; BASAL GANGLIA; CEREBRAL CORTEX; DEEP BRAIN STIMULATION; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON; OXIDOPAMINE; PARKINSON DISEASE; RATS; SUBTHALAMIC NUCLEUS; SYNAPTIC TRANSMISSION; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1;

EID: 84858017005     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032919     Document Type: Article

References (78)

1. McIntyre CC, Savasta M, Kerkerian-Le Goff L, Vitek JL, (2004) Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clinical Neurophysiology 115: 1239-1248.
2. Garcia L, D'Alessandro G, Bioulac B, Hammond C, (2005) High-frequency stimulation in Parkinson's disease: more or less? Trends Neurosci 28: 209-216.
3. Walker RH, Koch RJ, Sweeney JE, Moore C, Meshul CK, (2009) Effects of subthalamic nucleus lesions and stimulation upon glutamate levels in the dopamine-depleted rat striatum. Neuroreport 20: 770-775.
4. Meshul CK, Emre N, Nakamura CM, Allen C, Donohue MK, et al. (1999) Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience 88: 1-16.
5. Fremeau RT, Voglmaier S, Seal RP, Edwards RH, (2004) VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 27: 98-103.
6. Lacey CJ, Boyes J, Gerlach O, Chen L, Magill PJ, et al. (2005) GABA(B) receptors at glutamatergic synapses in the rat striatum. Neuroscience 136: 1083-1095.
7. Raju DV, Ahern TH, Shah DJ, Wright TM, Standaert DG, et al. (2008) Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of parkinsonism. Eur J Neurosci 27: 1647-1658.
8. Fujiyama F, Kuramoto E, Okamoto K, Hioki H, Furuta T, et al. (2004) Presynaptic localization of an AMPA-type glutamate receptor in corticostriatal and thalamostriatal axon terminals. Eur J Neurosci 20: 3322-3330.
9. Barroso-Chinea P, Castle M, Aymerich MS, Lanciego JL, (2008) Expression of vesicular glutamate transporters 1 and 2 in the cells of origin of the rat thalamostriatal pathway. J Chem Neuroanat 35: 101-107.
10. Barroso-Chinea P, Castle M, Aymerich MS, Perez-Manso M, Erro E, et al. (2007) Expression of the mRNAs encoding for the vesicular glutamate transporters 1 and 2 in the rat thalamus. J Comp Neurol 501: 703-715.
11. Raju DV, Smith Y, (2005) pp. 601-610 Differential localization of vesicular glutamate transporters 1 and 2 in the rat striatum.
12. Raju DV, Shah DJ, Wright TM, Hall RA, Smith Y, (2006) Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats. J Comp Neurol 499: 231-243.
13. Villalba RM, Smith Y, (2011) Differential structural plasticity of corticostriatal and thalamostriatal axo-spinous synapses in MPTP-treated Parkinsonian monkeys. J Comp Neurol 519: 989-1005.
14. Doig NM, Moss J, Bolam JP, (2010) Cortical and thalamic innervation of direct and indirect pathway medium-sized spiny neurons in mouse striatum. J Neurosci 30: 14610-14618.
15. Smith Y, Bennett BD, Bolam JP, Parent A, Sadikot AF, (1994) Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey. J Comp Neurol 344: 1-19.
16. Walker RH, Koch RJ, Moore C, Meshul CK, (2009) Subthalamic nucleus stimulation and lesioning have distinct state-dependent effects upon striatal dopamine metabolism. Synapse 63: 136-146.
17. Touchon JC, Moore C, Frederickson J, Meshul CK, (2004) Lesion of subthalamic or motor thalamic nucleus in 6-hydroxydopamine-treated rats: Effects on striatal glutamate and apomorphine-induced contralateral rotations. Synapse 51: 287-298.
18. Benazzouz A, Piallat B, Pollak P, Benabid AL, (1995) Responses of Substantia-Nigra Pars Reticulata and Globus-Pallidus Complex to High-Frequency Stimulation of the Subthalamic Nucleus in Rats- Electrophysiological Data. Neurosci Lett 189: 77-80.
19. Paul G, Reum T, Meissner W, Marburger A, Sohr R, et al. (2000) High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat. Neuroreport 11: 441-444.
20. Paxinos G, Watson C, (1998) The Rat Brain in Stereotaxic Coordinates. 4th.
21. McGeorge AJ, Faull RLM, (1989) The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29: 503-537.
22. Meshul CK, McGinty JF, (2000) Kappa opioid receptor immunoreactivity in the nucleus accumbens and caudate-putamen is primarily associated with synaptic vesicles in axons. Neuroscience 96: 91-99.
23. Schang AY, Fisher BE, Sashkin NR, Moore C, Dirling LB, et al. (2010) pp. 55-90 Correlates and analysis of motor function in humans and animal models of Parkinson's disease.
24. Phend KD, Weinberg RJ, Rustioni A, (1992) Techniques to optimize post-embedding single and double staining for amino acid neurotransmitters. J Histochem Cytochem 40: 1011-1020.
25. Meshul CK, Stallbaumer RK, Taylor B, Janowsky A, (1994) Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. Brain Res 648: 181-195.
26. See RE, Berglind WJ, Krentz L, Meshul CK, (2002) Convergent evidence from microdialysis and presynaptic immunolabeling for the regulation of gamma-aminobutyric acid release in the globus pallidus following acute clozapine or haloperidol administration in rats. J Neurochem 82: 172-180.
27. Ingham CA, Hood SH, Taggart P, Arbuthnott GW, (1998) Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J Neurosci 18: 4732-4743.
28. Moss J, Bolam JP, (2008) A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals. J Neurosci 28: 11221-11230.
29. Ingham CA, Hood SH, van Maldegem B, Weenink A, Arbuthnott GW, (1993) Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway. Exp Brain Res 93: 17-27.
30. Ingham CA, Hood SH, Arbuthnott GW, (1989) Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age. Brain Res 503: 334-338.
31. Neely MD, Schmidt DE, Deutch AY, (2007) Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons. Neuroscience 149: 457-464.
32. Day M, Wang Z, Ding J, An X, Ingham CA, et al. (2006) Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 9: 251-259.
33. Villalba RM, Lee H, Smith Y, (2009) Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys. Exp Neurol 215: 220-227.
34. Stephens B, Mueller AJ, Shering AF, Hood SH, Taggart P, et al. (2005) Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 132: 741-754.
35. Zaja-Milatovic S, Milatovic D, Schantz AM, Zhang J, Montine KS, et al. (2005) Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 64: 545-547.
36. Garcia BG, Neely MD, Deutch AY, (2010) Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss. Cereb Cortex 20: 2423-2432.
37. Tian X, Kai L, Hockberger PE, Wokosin DL, Surmeier DJ, (2010) MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. Mol Cell Neurosci 44: 94-108.
38. Sgambato-Faure V, Buggia V, Gilbert F, Levesque D, Benabid AL, et al. (2005) Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats. J Neuropathol Exp Neurol 64: 936-947.
39. Konradi C, Westin JE, Carta M, Eaton ME, Kuter K, et al. (2004) Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia. Neurobiol Dis 17: 219-236.
40. Tan A, Moratalla R, Lyford GL, Worley P, Graybiel AM, (2000) The activity-regulated cytoskeletal-associated protein arc is expressed in different striosome-matrix patterns following exposure to amphetamine and cocaine. J Neurochem 74: 2074-2078.
41. Fosnaugh JS, Bhat RV, Yamagata K, Worley PF, Baraban JM, (1995) Activation of arc, a putative "effector" immediate early gene, by cocaine in rat brain. J Neurochem 64: 2377-2380.
42. Waldau B, Clayton DA, Gasperson LB, Turner DA, (2011) Analysis of the time course of the effect of subthalamic nucleus stimulation upon hand function in Parkinson's patients. Stereotact Funct Neurosurg 89: 48-55.
43. Beurrier C, Bioulac B, Audin J, Hammond C, (2001) High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons. J Neurophysiol 85: 1351-1356.
44. Magarinos-Ascone C, Pazo JH, Macadar O, Buno W, (2002) High-frequency stimulation of the subthalamic nucleus silences subthalamic neurons: a possible cellular mechanism in Parkinson's disease. Neuroscience 115: 1109-1117.
45. Benazzouz A, Gao DM, Ni ZG, Piallat B, Rouali-Benazzouz R, et al. (2000) Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience 99: 289-295.
46. Tai CH, Boraud T, Bezard E, Bioulac B, Gross C, et al. (2003) Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. FASEB J 17: 1820-1830.
47. Hashimoto T, Elder CM, Okun MS, Patrick SK, Vitek JL, (2003) Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci 23: 1916-1923.
48. Lee KH, Kristic K, van Hoff R, Hitti FL, Blaha C, et al. (2007) High-frequency stimulation of the subthalamic nucleus increases glutamate in the subthalamic nucleus of rats as demonstrated by in vivo enzyme-linked glutamate sensor. Brain Res 1162: 121-129.
49. Carlson JD, Cleary DR, Cetas JS, Heinricher MM, Burchiel KJ, (2010) Deep brain stimulation does not silence neurons in subthalamic nucleus in Parkinson's patients. J Neurophysiol 103: 962-967.
50. Hahn PJ, McIntyre CC, (2010) Modeling shifts in the rate and pattern of subthalamopallidal network activity during deep brain stimulation. J Comput Neurosci 28: 425-441.
51. Miyachi S, Lu X, Imanishi M, Sawada K, Nambu A, et al. (2006) Somatotopically arranged inputs from putamen and subthalamic nucleus to primary motor cortex. Neurosci Res 56: 300-308.
52. Nambu A, Tokuno H, Takada M, (2002) Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway. Neurosci Res 43: 111-117.
53. Li S, Arbuthnott GW, Jutras MJ, Goldberg JA, Jaeger D, (2007) Resonant antidromic cortical circuit activation as a consequence of high-frequency subthalamic deep-brain stimulation. J Neurophysiol 98: 3525-3537.
54. Kuhn AA, Kempf F, Brucke C, Gaynor DL, Martinez-Torres I, et al. (2008) High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance. J Neurosci 28: 6165-6173.
55. Morari M, Oconnor WT, Ungerstedt U, Bianchi C, Fuxe K, (1996) Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat. 2. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral gabaergic transmission and motor function. Neuroscience 72: 89-97.
56. Biggs CS, Starr MS, (1997) Dopamine and glutamate control each other's release in the basal ganglia: a microdialysis study of the entopeduncular nucleus and substantia nigra. Neurosci Biobehav Rev 21: 497-504.
57. Villalba RM, Smith Y, (2010) Striatal spine plasticity in Parkinson's disease. Front Neuroanat 4: 133.
58. Meshul CK, Kamel D, Moore C, Kay TS, Krentz L, (2002) Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats. Exp Neurol 175: 257-274.
59. Robinson S, Freeman P, Moore C, Touchon JC, Krentz L, et al. (2003) Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function. Exp Neurol 180: 74-87.
60. Jonkers N, Sarre S, Ebinger G, Michotte Y, (2002) MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats. Brain Research 926: 149-155.
61. Gubellini P, Eusebio A, Oueslati A, Melon C, Kerkerian-Le Goff L, et al. (2006) Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission. Eur J Neurosci 24: 1802-1814.
62. Picconi B, Centonze D, Rossi S, Bernardi G, Calabresi P, (2004) Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. Brain 127: 1661-1669.
63. Centonze D, Gubellini P, Rossi S, Picconi B, Pisani A, et al. (2005) Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental Parkinsonism. Neuroscience 133: 831-840.
64. Lindefors N, Ungerstedt U, (1990) Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons. Neurosci Lett 115: 248-252.
65. Aymerich MS, Barroso-Chinea P, Perez-Manso M, Munoz-Patino AM, Moreno-Igoa M, et al. (2006) Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats. Eur J Neurosci 23: 2099-2108.
66. Corsi C, Pinna A, Gianfriddo M, Melani A, Morelli M, et al. (2003) Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats. Eur J Pharmacol 464: 33-38.
67. Galeffi F, Bianchi L, Bolam JP, Della CL, (2003) The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis. Eur J Neurosci 18: 856-868.
68. Robelet S, Melon C, Guillet B, Salin P, Kerkerian-Le Goff L, (2004) Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease. Eur J Neurosci 20: 1255-1266.
69. Herrera-Marschitz M, You ZB, Goiny M, Meana JJ, Silveira R, et al. (1996) On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis. J Neurochem 66: 1726-1735.
70. Baker DA, Xi ZX, Shen H, Swanson CJ, Kalivas PW, (2002) The origin and neuronal function of in vivo nonsynaptic glutamate. J Neurosci 22: 9134-9141.
71. Massie A, Schallier A, Mertens B, Vermoesen K, Bannai S, et al. (2008) Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats. Neuroreport 19: 1589-1592.
72. Danbolt NC, (2001) Glutamate uptake. Prog Neurobiol 65: 1-105.
73. Chung EK, Chen LW, Chan YS, Yung KK, (2008) Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats. J Comp Neurol 511: 421-437.
74. Lievens JC, Salin P, Nieoullon A, Kerkerian-Le Goff L, (2001) Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum. J Neurochem 79: 893-902.
75. Massie A, Goursaud S, Schallier A, Vermoesen K, Meshul CK, et al. (2010) Time dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats. Neurochem Int 57: 572-578.
76. Massie A, Schallier A, Vermoesen K, Arckens L, Michotte Y, (2010) Biphasic and bilateral changes in striatal VGLUT1 and 2 protein expression in hemi-Parkinson rats. Neurochem Int 57: 111-118.
77. Hollerman JR, Grace AA, (1990) The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons. Brain Res 533: 203-212.
78. Castaneda E, Whishaw IQ, Robinson TE, (1990) Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J Neurosci 10: 1847-1854.